| Bioactivity | Anticancer agent 7 (Example 5) is an anti-cancer agent with an IC50 of 5 μM for H1650 lung cancer cells[1]. | ||||||||||||
| Invitro | Anticancer agent 7 exhibits anti-proliferative effects. Anticancer agent 7 is useful in the treatment of a variety of disorders, including as a therapy in cancer treatment[1]. Cell Viability Assay[1] Cell Line: | ||||||||||||
| Name | Anticancer agent 7 | ||||||||||||
| CAS | 2088956-21-0 | ||||||||||||
| Formula | C24H19Cl2F3N2O5S | ||||||||||||
| Molar Mass | 575.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Michael Ohlmeyer, et al. Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents. WO2017044569A1. |
Anticancer agent 7
CAS: 2088956-21-0 F: C24H19Cl2F3N2O5S W: 575.38
Anticancer agent 7 (Example 5) is an anti-cancer agent with an IC50 of 5 μM for H1650 lung cancer cells.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.